Introduction {#s1}
============

Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disorder with diverse clinical manifestations. It can be potentially fatal when major organs are affected. The prevalence of SLE ranges from approximately 20 to 150 cases per 100,000 persons worldwide [@pone.0069547-Tsokos1], with a female-to-male ratio of 9∶1 [@pone.0069547-DCruz1]. People of Afro-Caribbean and Asian ethnicity are more likely to develop this disorder than white people [@pone.0069547-Danchenko1]. Sunlight, drugs and some occupational exposures could trigger the disorder [@pone.0069547-DCruz1]. Infections of Epstein-Barr virus and bacteria have also been identified as possible factors in the development of SLE, but no one specific cause has been identified [@pone.0069547-DCruz1]. A strong familial aggregation has been found in SLE [@pone.0069547-AlarconRiquelme1]; the concordance rate is higher in monozygotic twins than in dizygotic twins [@pone.0069547-Sullivan1]. These facts suggest that genetic factors play a role in the development of SLE.

Interleukin 10 (IL-10), primarily produced by monocytes and lymphocytes, is a multifunctional cytokine in immunoregulation and inflammation. There are several lines of evidence suggesting that the *IL-10* gene is a candidate gene for SLE susceptibility. IL-10 enhances B cell proliferation, differentiation and antibody production, and therefore plays a role in B cell hyperactivity and in increasing production of autoantibodies in SLE [@pone.0069547-Llorente1], [@pone.0069547-Rousset1]. It also inhibits functions of T cells and antigen-presenting cells [@pone.0069547-deWaalMalefyt1], [@pone.0069547-Taga1], which in SLE may contribute to impaired cell-mediated immunity. Several studies have found that IL-10 production is high in SLE patients and IL-10 serum level correlates with disease activity [@pone.0069547-Hagiwara1], [@pone.0069547-Horwitz1], [@pone.0069547-Houssiau1], [@pone.0069547-Lacki1], [@pone.0069547-Llorente2], [@pone.0069547-Llorente3], [@pone.0069547-Park1]. Studies in lupus animal models and humans have shown that anti-IL-10 treatment can decrease disease activity in terms of clinical features and biologic markers [@pone.0069547-Ishida1], [@pone.0069547-Lauwerys1], [@pone.0069547-Llorente4].

In humans, the *IL-10* gene is located on chromosome 1q and encodes for 5 exons. The *IL-10* promoter is highly polymorphic and in this region two CA-repeat microsatellites (*IL-10.G* and *IL-10.R*) and three single nucleotide polymorphisms (SNPs) at positions −1082, −819, and −592 from the transcription start site, have been identified to correlate with IL-10 production [@pone.0069547-Iyer1]. Haplotypes comprising three SNPs at positions −1082, −819, and −592 have also been found to correlate with IL-10 serum level [@pone.0069547-Iyer1].

Considering the role of IL-10 in SLE and the relationship between the *IL-10* gene polymorphisms and IL-10 production, a number of observational studies have been conducted to investigate the association of the *IL-10* gene polymorphisms with SLE susceptibility. However, their results are conflicting. This can be due to insufficient power, small effect of the *IL-10* gene polymorphisms on SLE susceptibility, and false-positive results. Meta-analysis is a statistical method that can overcome the limitations of individual studies [@pone.0069547-Egger1]. We therefore performed a meta-analysis to clarify the inconsistency among studies and to establish a comprehensive picture of the association between the *IL-10* gene polymorphisms and SLE susceptibility.

Methods {#s2}
=======

Searching {#s2a}
---------

We searched PubMed, EMBASE and Chinese Biomedical Literature Database for relevant reports without language restriction. The last search update was performed on August 31, 2012. The search strategies were based on the following form: (interleukin-10 or synonyms) AND ("systemic lupus erythematosus" or synonyms). Both thesaurus terms and free text were used. Detailed description of the search strategies can be found in supplementary materials (see [Method S1](#pone.0069547.s001){ref-type="supplementary-material"}). We also screened references of retrieved articles and relevant reviews for additional studies. Any case-control designed studies were considered eligible if they aimed to investigate the relation between the *IL10* gene polymorphisms and SLE risk, no matter which polymorphisms were studied or whether they provided enough data to calculate odds ratios (ORs). Family-based studies were excluded because of linkage considerations.

Two authors (PL, JS) independently screened all reports by title or abstract for those requiring further retrieval, and then independently reviewed these studies for eligibility. Discrepancies were resolved by group discussion. Following information was extracted using predetermined forms: the first author's name, year of publication, ethnicity, definition and numbers of cases and controls, genotyping method, frequency of *IL10* genotypes, and consistency of genotype frequencies with Hardy-Weinberg equilibrium (HWE). We compared author names, authors' affiliations, and geographic locations and period of studies to identify sequential or multiple publications. If more than one report related to the same or overlapping data sets, we included results from the largest or most recent publication.

Statistical Analysis {#s2b}
--------------------

We calculated odds ratios with 95% confidence intervals (CIs) to assess the strength of the association between the *IL10* gene polymorphisms and SLE risk. For each allele or haplotype with enough data sets, we performed overall analysis as well as subgroup analysis on the basis of population ethnicity and HWE in control groups, as genotype frequencies are often different across ethnicities and deviating from HWE may be a sign of selection bias or population stratification. HWE was tested using the χ^2^ test and it was considered statistically significant when the *P* value is less than 0.05 [@pone.0069547-Yu1].

For SNPs, we adopt four genetic models to evaluate their association with SLE risk: major allele vs. minor allele, major allele homozygotes vs. minor allele homozygotes, major allele homozygotes vs. heterozygotes plus minor allele homozygotes, and major allele homozygotes plus heterozygotes vs. minor allele homozygotes.

Heterogeneity was determined using the *P* value from the χ^2^ test (Cochran's *Q* statistic) and the *I* ^2^ statistic. The *I* ^2^ statistic represents the proportion of variation in the study estimates due to heterogeneity, in which 0--40% may be unimportant heterogeneity, 30--60% indicates moderate, 50--90% indicates substantial and 75--100% indicates considerable heterogeneity [@pone.0069547-Dang1]. When the *P* value from the χ^2^ test was more than 0.10, the summary OR estimate was calculated by the fixed-effect model [@pone.0069547-Mantel1]. Otherwise, the random-effect model was used [@pone.0069547-DerSimonian1]. Publication bias was investigated by funnel plot and Egger's linear regression test [@pone.0069547-Egger2]. All statistical analyses were done with STATA version 10.0 (StataCorp LP, College Station, Texas, USA). This meta-analysis does not have a protocol. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist is available in supplementary materials (see [Method S2](#pone.0069547.s002){ref-type="supplementary-material"}).

Results {#s3}
=======

Study Characteristics {#s3a}
---------------------

By screening title or abstract and further evaluating full-text, we identified 38 case-control studies from PubMed and EMBASE and 8 from Chinese Biomedical Literature Database. 5 of them were excluded because of duplication reports or using the same or overlapping data sets. One publication contained two individual case-control studies. At last, 41 publications with 42 case-control studies were included in this review (see [Reference S1](#pone.0069547.s003){ref-type="supplementary-material"}). [Figure 1](#pone-0069547-g001){ref-type="fig"} describes the study selection process.

![Flow diagram of the study selection process.](pone.0069547.g001){#pone-0069547-g001}

These 42 case-control studies were published from 1997 to 2011 with 33 in English, 6 in Chinese, 1 in Russian and 1 in Bulgarian. They included 7948 cases and 11866 controls. All studies used healthy people as controls. Ethnic groups among these studies were as following: 20 were Asians, 16 were Caucasians, 2 were Mexicans, 1 was African, 1 was Colombian, 1 was Kazakh, and 1 was mixed populations. [Table 1](#pone-0069547-t001){ref-type="table"} shows a brief description of these 42 case-control studies.

10.1371/journal.pone.0069547.t001

###### Characteristics of included studies in this meta-analysis.

![](pone.0069547.t001){#pone-0069547-t001-1}

  Study                       Ref.   Ethnicity     Country     SLE    Control      Genotype method                                                        Studied polymorphisms                                                                                          Findings
  -------------------------- ------ ----------- ------------- ------ --------- ----------------------- --------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------
  Eskdale (1997)               1     Caucasian       UK         56      102           Genescan                                                               IL10.G, IL10.R                                                                                   CA21, CA25 associated with SLE
  Lazarus (1997)               2     Caucasian       UK         76      119              ASO                                                                −1082, −819, −592                                                                                         No association
  Mehrian (1998)               3      Mexican        USA       158      220           Genescan                                                                   IL10.G                                                                    CA22, CA23 associated with SLE (P = 0.0001, P = 0.015, respectively)
  Mok (1998)                   4       Asian        China       88      83              RFLP                                                                −1082, −819, −592                                                                                         No association
  Ou (1998)                    5       Asian        China      100      103           Genescan                                                                   IL10.G                                                                                               No association
  Alarcon-Riquelme (1999)      6      Mexican      Mexico      330      368           Genescan                                                                   IL10.G                                                                                               No association
  Crawley (1999)               7     Caucasian       UK        120      274              ASO                                                                −1082, −819, −592                                                                                         No association
  Rood (1999)                  8     Caucasian   Netherlands    92      162              ASO                                                                −1082, −819, −592                                                                                         No association
  D\'Alfonso 1 (2000)          9     Caucasian      Italy       98      104           Genescan                                                               IL10.G, IL10.R                                                                                CA23 associated with SLE (P = 0.0425)
  D\'Alfonso 2 (2000)          10    Caucasian      Italy       68      64            Genescan                                                                   IL10.G                                                                                    CA23 associated with SLE (P = 0.0470)
  Gibson (2002)                11     African        USA        60      64           Sequencing                                                            −3575, −2849, −2763                                                                              −2763 associated with SLE (P\<0.05)
  D\'Alfonso (2002)            12    Caucasian      Italy      205      631             HPLC                          26 SNPs including −1082, −592, −3575,−2849[\#](#nt102){ref-type="table-fn"}, −2763 and IL10.G                               IL10G long alleles (CA repeat \>21) associated with SLE
  Dijstelbloem (2002)          13    Caucasian   Netherlands   180      163              ASO                                                                      −1082                                                                                               No association
  Guseva (2003)                14     Kazakh       Russia       49      71             PCR-SSP                                                                    −592                                                                                     −592 associated with SLE (P = 0.003)
  Shen (2003)                  15      Asian        China      220      230       Genescan, PCR-SSP                                                  IL10G, IL10R, −1082, −819, −592                                                CA21, CA22, −1082 associated with SLE (P = 0.009, 0.006 and \<0.0001, respectively)
  Chong (2004)                 16      Asian        China      554      708     Genescan, Taqman,RFLP   IL10.G, IL10.R [\#](#nt102){ref-type="table-fn"}, −1082, −819, −592, −3575,−2849 [\#](#nt102){ref-type="table-fn"}, −2763             −592, CA16 associated with SLE (0.009 and 0.017, respectively)
  Fei (2004)                   17    Caucasian     Sweden       52      26              RFLP                                                                      −1082                                                                                     −1082 associated with SLE (P\<0.05)
  Schotte (2004)               18    Caucasian     Germany     210      158           Genescan                                                               IL10.G, IL10.R                                                                                           No association
  Guzowski (2005)              19      Mixed         USA        48      25              HPLC                                                                −1082, −819, −592                                                                                          Not estimate
  Hrycek (2005)                20    Caucasian     Poland       24      36             PCR-SSP                                                              −1082, −819, −592                                                                                         No association
  Khoa (2005)                  21      Asian       Vietnam      64      57             PCR-SSP                                                                    −1082                                                                                     −1082 associated with SLE (P\<0.05)
  Lu (2005)                    22      Asian        China      136      115             RFLP                                                                      −819                                                                                     −819 associated with SLE (P = 0.009)
  Suarez (2005)                23    Caucasian      Spain      187      343              ASO                                                                   −1082, −592                                                                                            No association
  Zhu (2005)                   24      Asian        China      265      100             RFLP                                                                      −592                                                                                                No association
  Chen (2006)                  25      Asian        China      237      304           Genescan                                                                   IL10.G                                                                                    CA20 associated with SLE (P\<0.0001)
  Hirankarn (2006)             26      Asian      Thailand     195      159              MS                                                                 −1082, −819, −592                                                                          Haplotype ACC associated with SLE (P = 0.03)
  Sung (2006)                  27      Asian        Korea      350      330           SNaPshot                                                     9 SNPs including −1082, −819, −592                                                                                 No association
  Guarnizo-Zuccardi (2007)     28    Colombian    Colombia     120      102            PCR-SSP                                                              −1082, −819, −592                                                                                         No association
  Lin (2007)                   29      Asian        China      119      100             RFLP                                                                      −592                                                                                     −592 associated with SLE (P = 0.003)
  Lan (2007)                   30      Asian        China       90      110             RFLP                                                                −1082, −819, −592                                                                      −1082 and haplotype GCC associated with SLE (P\<0.05)
  Wang (2007)                  31      Asian        China       83      125             RFLP                                                                −1082, −819, −592                                                             −819, −592, haplotype ACC, haplotype ATA associated with SLE (P\<0.001)
  Xu (2007)                    32      Asian        China      103      110             RFLP                                                                  −3575, −2763                                                                                  −3575 associated with SLE (P\<0.05)
  Zhou (2007)                  33      Asian        China      137      122             RFLP                                                                −1082, −819, −592                                                                            −1082 and associated with SLE (P\<0.001)
  Hee (2008)                   34      Asian      Malaysia      44      44              RFLP                                                                −1082, −819, −592                                                                          haplotype GCC associated with SLE (P = 0.004)
  Miyagawa (2008)              35      Asian        Japan      264      695          PLACE-SSCP                                                        5 SNPs including −819, −592                                                                                    No association
  Rosado (2008)                36    Caucasian      Spain      116      151        Genescan, RFLP                                                    IL10G, IL10R, −1082, −819, −592                                                                           Haplotype GCC, ACC (P\<0.05)
  Gateva (2009)                37    Caucasian   USA, Sweden   1963    4329           SNP array                                                            Over 12000 variants                                                                                  rs3024505 (P = 3.95×10^−8^)
  Sobkowiak (2009)             38    Caucasian     Poland      103      300          Sequencing                                                             −1082, −819, −592                                                                                   Haplotype GCC (P = 0.0022)
  Lin (2010)                   39      Asian        China      172      215            Taqman                                                               −1082, −819, −592                                                                                    Haplotype ATA (P\<0.001)
  Miteva (2010)                40    Caucasian    Bulgaria     157      126            PCR-SSP                                                                    −1082                                                                                               No association
  Yu (2010)                    41      Asian        China      110      138           SNPstream                                                             −1082, −819, −592                                                                                         No association
  Ren (2011)                   42      Asian        China      145      80              RFLP                                                                      −592                                                                                                No association

ASO: allele-specific oligonucleotid hybridization; RFLP: restriction fragment length polymorphism; PCR-SSP: polymerase chain reaction sequence specific primer; HPLC: high-performance liquid chromatography; MS: mass spectrometry; PLACE-SSCP post-PCR fluorescent labeling and automated capillary electrophoresis under single-strand conformation polymorphism conditions; SNPs: single nucleotide polymorphisms.

no polymorphisms.

Of the 42 studies investigating the association of the *IL-10* gene polymorphisms with SLE, 11 studied the *IL10.G* microsatellites, 6 studied the *IL-10.R* microsatellites, 24 studied −1082, 20 studied −819, 26 studied −592, 4 studied −3575 and 4 studied −2763. For other SNPs, there was only one study.

Association of the IL10.G and IL10.R Microsatellites with SLE Susceptibility {#s3b}
----------------------------------------------------------------------------

Of the 11 studies investigating the association between the *IL10.*G microsatellites and SLE susceptibility, 10 provided enough data to calculate ORs ([Table 2](#pone-0069547-t002){ref-type="table"}). By pooling the 10 studies, the meta-analyses showed that only CA27 allele of the *IL10.G* was associated with SLE (OR 1.32, 95% CI 1.01--1.72) and there was no significant between-study heterogeneity. Further subgroup analyses showed that this association was found among Caucasians (OR 2.38, 95% CI 1.01--5.62), but not among other populations. Subgroup analyses also showed that the CA21 allele of the *IL10.G* was associated with SLE among Asians (OR 1.28, 95% CI 1.02--1.60). But there was substantial between-study heterogeneity. As described previously, we also divided all alleles of the *IL10.*G microsatellites into long allele (\>21 CA repeats) and short allele (≤21 CA repeats). No association was found between them and SLE.

10.1371/journal.pone.0069547.t002

###### Meta-analysis of the IL-10.G and IL-10.R microsatellites with SLE.

![](pone.0069547.t002){#pone-0069547-t002-2}

  Genetic model          Population   Study        OR (95% CI)        Statistical model   I^2^    *P* ~Heterogeneity~   *P* ~Egger's\ test~
  --------------------- ------------ ------- ----------------------- ------------------- ------- --------------------- ---------------------
  IL-10.G CA21            Overall      10       1.03 (0.85--1.25)          Random         77.0%         \<0.001                0.512
                         Caucasian      4       0.86 (0.62--1.20)          Random         58.9%          0.063                 0.327
                          Mexican       2       0.84 (0.42--1.76)          Random         92.9%         \<0.001                 --
                           Asian        4     **1.28 (1.02--1.60)**        Random         67.4%          0.027                 0.199
  IL-10.G CA22            Overall      10       1.10 (0.83--1.45)          Random         72.1%         \<0.001                0.352
                         Caucasian      4       1.33 (0.88--1.99)           Fixed         0.0%           0.947                 0.170
                          Mexican       2       1.59 (0.54--4,69)          Random         94.2%         \<0.001                 --
                           Asian        4       0.86 (0.73--1.01)           Fixed         45.8%          0.137                 0.829
  IL-10.G CA23            Overall      10       1.18 (0.88--1.57)          Random         41.5%          0.081                 0.555
                         Caucasian      4       1.30 (0.76--2.25)          Random         61.8%          0.049                 0.770
                          Mexican       2       1.22 (0.88--1.70)           Fixed         62.8%          0.101                  --
                           Asian        4       0.96 (0.61--1.49)           Fixed         25.2%          0.260                 0.371
  IL-10.G CA24            Overall      10       0.84 (0.68--1.03)           Fixed         5.9%           0.387                 0.798
                         Caucasian      4       0.93 (0.51--1.69)          Random         54.5%          0.086                 0.484
                          Mexican       2       0.87 (0.63--1.20)           Fixed         0.0%           0.452                  --
                           Asian        4       0.77 (0.54--1.11)           Fixed         0.0%           0.551                 0.267
  IL-10.G CA25            Overall      10       0.77 (0.58--1.03)          Random         77.2%         \<0.001                0.490
                         Caucasian      4       0.54 (0.27--1.05)          Random         87.8%         \<0.001                0.577
                          Mexican       2       1.00 (0.78--1.28)           Fixed         0.0%          0.646%                  --
                           Asian        4       0.92 (0.74--1.13)           Fixed         1.8%           0.383                 0.710
  IL-10.G CA26            Overall      10       1.04 (0.89--1.22)           Fixed         0.0%           0.816                 0.369
                         Caucasian      4       1.11 (0.77--1.61)           Fixed         0.0%           0.763                 0.968
                          Mexican       2       0.88 (0.62--1.23)           Fixed         0.0%           0.350                  --
                           Asian        4       1.08 (0.89--1.32)           Fixed         0.0%           0.582                 0.147
  IL-10.G CA27            Overall      10     **1.32 (1.01--1.72)**         Fixed         8.2%           0.366                 0.561
                         Caucasian      4     **2.38 (1.01--5.62)**         Fixed         0.0%           0.785                 0.536
                          Mexican       2       1.22 (0.83--1.79)           Fixed         56.5%          0.129                  --
                           Asian        4       1.23 (0.82--1.86)           Fixed         35.0%          0.201                 0.213
  IL-10.G CA28            Overall       9       1.06 (0.72--1.58)           Fixed         0.5%           0.429                 0.839
                         Caucasian      3       1.03 (0.25--4.22)           Fixed         0.0%           0.699                  --
                          Mexican       2       0.67 (0.28--1.57)           Fixed         0.0%           0.542                  --
                           Asian        4       1.24 (0.77--2.01)           Fixed         46.8%          0.130                 0.946
  IL-10.G Long allele     Overall      10       0.85 (0.64--1.12)          Random         88.5%         \<0.001                0.300
                         Caucasian      4       0.64 (0.28--1.45)          Random         93.1%         \<0.001                0.392
                          Mexican       2       1.25 (0.57--2.75)          Random         94.7%         \<0.001                 --
                           Asian        4       0.86 (0.68--1.10)          Random         70.3%          0.018                 0.322
  IL-10.R R2             Caucasian      3       0.97 (0.77--1.23)          Random         63.9%          0.063                 0.415
  IL-10.R R3             Caucasian      3       1.00 (0.67--1.50)          Random         60.9%          0.077                 0.308
  IL-10.R R4             Caucasian      3       0.85 (0.38--1.89)           Fixed         0.0%           0.443                 0.702

OR: odds ratio; CI: confidence interval; SLE: systemic lupus erythematosus.

For the *IL10.R* microsatellites, only 3 studies were available to calculate ORs. They all studied Caucasians. The meta-analyses found no association between the *IL10.R* microsatellites and SLE.

Association of the IL10 −1082G/A Polymorphism with SLE Susceptibility {#s3c}
---------------------------------------------------------------------

Of the 24 studies investigating the association between the *IL10* −1082G/A polymorphism and SLE susceptibility, 23 provided enough data to calculate ORs ([Table 3](#pone-0069547-t003){ref-type="table"}). The results of pooling all studies showed that the *IL10* −1082 G/A polymorphism was not associated with SLE susceptibility under any genetic models. After excluding studies deviating from HWE [@pone.0069547-Lazarus1], [@pone.0069547-Zhou1], the results showed that the *IL10* −1082G allele was associated with increased SLE risk under three genetic models (G vs. A: OR 1.21, 95% CI 1.02--1.44; GG vs. AA: OR 1.45, 95% CI 1.16--1.82; GG+GA vs. AA: OR 1.16, 95% CI 1.03--1.29).

10.1371/journal.pone.0069547.t003

###### Meta-analysis of the *IL10* −1082G/A polymorphism and SLE.
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  Genetic model    Population                  Study                       OR (95% CI)        Statistical model   I^2^    *P* ~Heterogeneity~   *P* ~Egger's\ test~
  --------------- ------------ ------------------------------------- ----------------------- ------------------- ------- --------------------- ---------------------
  G vs. A           Overall                     23                      1.13 (0.92--1.37)          Random         78.5%         \<0.001                0.628
                                21[\*](#nt105){ref-type="table-fn"}   **1.21 (1.02--1.44)**        Random         69.2%         \<0.001                0.797
                                20[\#](#nt106){ref-type="table-fn"}   **1.15 (1.05--1.25)**         Fixed         26.4%          0.135                 0.299
                   Caucasian                    10                    **1.16 (1.04--1.28)**         Fixed         28.3%          0.184                 0.885
                                9[\*](#nt105){ref-type="table-fn"}    **1.15 (1.03--1.28)**         Fixed         33.8%          0.147                 0.996
                     Asian                      11                      1.08 (0.65--1.81)          Random         88.6%         \<0.001                0.558
                                10[\*](#nt105){ref-type="table-fn"}     1.28 (0.84--1.95)          Random         80.0%         \<0.001                0.185
                                9[\#](#nt106){ref-type="table-fn"}      1.19 (0.98--1.44)           Fixed         32.1%          0.161                 0.076
  GG vs. AA         Overall                     15                      1.24 (0.82--1.86)          Random         66.9%         \<0.001                0.608
                                13[\*](#nt105){ref-type="table-fn"}   **1.45 (1.16--1.82)**         Fixed         34.7%          0.104                 0.892
                   Caucasian                     9                    **1.43 (1.13--1.81)**         Fixed         33.5%          0.150                 0.877
                                8[\*](#nt105){ref-type="table-fn"}    **1.40 (1.10--1.79)**         Fixed         40.4%          0.109                 0.830
                     Asian                       4                      0.99 (0.10--9.75)          Random         87.1%         \<0.001                 --
                                3[\*](#nt105){ref-type="table-fn"}    **3.21 (1.24--8.28)**         Fixed         18.4%          0.294                  --
  GG+GA vs. AA      Overall                     17                      1.07 (0.89--1.28)          Random         61.7%         \<0.001                0.434
                                15[\*](#nt105){ref-type="table-fn"}   **1.16 (1.03--1.29)**         Fixed         0.0%           0.610                 0.501
                   Caucasian                     9                    **1.16 (1.03--1.32)**         Fixed         0.0%           0.749                 0.982
                                8[\*](#nt105){ref-type="table-fn"}    **1.15 (1.01--1.31)**         Fixed         0.0%           0.706                 0.838
                     Asian                       6                      0.93 (0.51--1.69)          Random         84.7%         \<0.001                0.948
                                5[\*](#nt105){ref-type="table-fn"}      1.26 (0.99--1.62)           Fixed         24.2%          0.260                 0.560
  GG vs. AA+GA      Overall                     15                      1.14 (0.81--1.61)          Random         66.1%         \<0.001                0.804
                                13[\*](#nt105){ref-type="table-fn"}     1.30 (0.94--1.78)          Random         50.6%          0.019                 0.907
                   Caucasian                     9                      1.22 (0.89--1.67)          Random         56.1%          0.020                 0.911
                                8[\*](#nt105){ref-type="table-fn"}      1.22 (0.85--1.76)          Random         61.5%          0.011                 0.924
                     Asian                       4                      1.18 (0.22--6.27)          Random         82.2%          0.001                  --
                                3[\*](#nt105){ref-type="table-fn"}    **2.85 (1.19--6.79)**         Fixed         4.7%           0.350                  --

OR: odds ratio; CI: confidence interval; SLE: systemic lupus erythematosus.

exclude the studies deviating from Hardy-Weinberg equilibrium.

exclude the study by Shen (2003).

In the subgroup analyses by ethnicity, the results showed that the *IL10* −1082G allele was associated with increased SLE risk among Caucasians under three genetic models (G vs. A: OR 1.16, 95% CI 1.04--1.28; GG vs. AA: OR 1.43, 95% CI 1.13--1.81; GG+GA vs. AA: OR 1.16, 95% CI 1.03--1.32), while the associations were not found among Asians under any genetic model. After excluding studies deviating from HWE [@pone.0069547-Lazarus1], [@pone.0069547-Zhou1], the results hardly changed for Caucasians, while for Asians statistically significant associations were found under the genetic models of GG vs. AA (OR 3.21, 95% CI 1.24--8.28) and GG vs. AA+GA (OR 2.85, 95% CI 1.19--6.79) and a close but not statistically significant association was found under the genetic model of GG+GA vs. AA (OR 1.26, 95% CI 0.99--1.62).

The heterogeneity was significant in the pooling analyses of total available studies and in the subgroup analyses of Asians. Deviating from HWE in control groups can explain much of it. When excluding studies deviating from HWE could not eliminate the heterogeneity or eliminate it little, we excluded one more study. By this way, we found that the study by Shen contributed much heterogeneity in the pooling analysis and the subgroup analysis of Asians [@pone.0069547-Shen1]. After excluding the study deviating from HWE and the study by Shen [@pone.0069547-Zhou1], [@pone.0069547-Shen1], a close but not statistically significant association was found among Asians using the genetic model of G vs. A (OR 1.19, 95% CI 0.98--1.44). In the subgroup analyses of Caucasians, the heterogeneity was not important under genetic models of G vs. A, GG vs. AA and GG+GA vs. AA, but under the model of GG vs. AA+GA. Excluding studies deviating from HWE and excluding one more study eliminated the heterogeneity little. Results from funnel plot and Egger's test suggested that publication bias was not evident (*P* ~Egger's\ test~\>0.05, [Table 3](#pone-0069547-t003){ref-type="table"}).

Association of the IL10 −819C/T Polymorphism with SLE Susceptibility {#s3d}
--------------------------------------------------------------------

Of the 20 studies investigating the association between the *IL10* −819C/T polymorphism and SLE susceptibility, 18 provided enough data to calculate ORs ([Table 4](#pone-0069547-t004){ref-type="table"}). The results of pooling all studies showed that the *IL10* −819C/T polymorphism was not associated with SLE susceptibility under any genetic models. Ethnicity, consistency with HWE, and adjustment for heterogeneity did not affect the results.

10.1371/journal.pone.0069547.t004

###### Meta-analysis of the *IL10* −819C/T polymorphism and SLE.

![](pone.0069547.t004){#pone-0069547-t004-4}

  Genetic model    Population                  Study                     OR (95% CI)      Statistical model   I^2^      *P*     *P* ~Egger's\ test~
  --------------- ------------ ------------------------------------- ------------------- ------------------- ------- --------- ---------------------
  C vs. T           Overall                     18                    0.91 (0.75--1.10)        Random         73.5%   \<0.001          0.232
                                14[\*](#nt108){ref-type="table-fn"}   0.90 (0.72--1.11)        Random         71.7%   \<0.001          0.107
                                13[\#](#nt109){ref-type="table-fn"}   1.04 (0.93--1.17)         Fixed         11.5%    0.330         **0.002**
                   Caucasian                     6                    0.95 (0.80--1.13)         Fixed         0.0%     0.700           0.138
                     Asian                      10                    0.94 (0.69--1.28)        Random         84.6%   \<0.001          0.580
                                7[\*](#nt108){ref-type="table-fn"}    0.91 (0.62--1.33)        Random         85.4%   \<0.001          0.356
                                6[\#](#nt109){ref-type="table-fn"}    1.15(0.99--1.34)          Fixed         3.7%     0.393           0.142
  CC vs. TT         Overall                     13                    0.87 (0.66--1.16)         Fixed         29.0%    0.154         **0.013**
                                9[\*](#nt108){ref-type="table-fn"}    0.93 (0.65--1.33)         Fixed         0.0%     0.734           0.165
                   Caucasian                     6                    0.90 (0.59--1.37)         Fixed         0.0%     0.712           0.449
                     Asian                       5                    1.09 (0.71--1.68)         Fixed         47.7%    0.105         **0.002**
                                2[\*](#nt108){ref-type="table-fn"}    1.27 (0.62--2.64)         Fixed         0.0%     0.482            --
  CC+CT vs. TT      Overall                     13                    0.89 (0.63--1.25)        Random         59.0%    0.004           0.647
                                9[\*](#nt108){ref-type="table-fn"}    0.97 (0.72--1.31)         Fixed         0.0%     0.799           0.128
                   Caucasian                     6                    0.91 (0.60--1.37)         Fixed         0.0%     0.712           0.629
                     Asian                       5                    1.04 (0.59--1.81)        Random         81.1%   \<0.001          0.569
                                2[\*](#nt108){ref-type="table-fn"}    1.12 (0.70--1.81)         Fixed         0.0%     0.398            --
  CC vs. TT+CT      Overall                     13                    0.94 (0.79--1.13)         Fixed         0.0%     0.511           0.141
                                9[\*](#nt108){ref-type="table-fn"}    0.94 (0.77--1.15)         Fixed         0.0%     0.665           0.291
                   Caucasian                     6                    0.94 (0.76--1.17)         Fixed         0.0%     0.679           0.146
                     Asian                       5                    1.05 (0.69--1.59)         Fixed         27.0%    0.241         **0.014**
                                2[\*](#nt108){ref-type="table-fn"}    1.23 (0.63--2.42)         Fixed         0.0%     0.657            --

OR: odds ratio; CI: confidence interval; SLE: systemic lupus erythematosus.

exclude the studies deviating from Hardy-Weinberg equilibrium.

exclude the study by Wang (2007).

The heterogeneity was significant in the overall analyses and the subgroup analyses of Asians under the genetic models of C vs. T and CC+CT vs. TT. After excluding studies deviating from HWE and the study by Wang [@pone.0069547-Zhou1], [@pone.0069547-Lin1], [@pone.0069547-Lu1], [@pone.0069547-Wang1], the heterogeneity was eliminated. Results from funnel plot and Egger's test suggested that publication bias was present in the studies investigating the association between the *IL10* −819C/T polymorphism and SLE ([Table 4](#pone-0069547-t004){ref-type="table"}).

Association of the IL10 −592C/A Polymorphism with SLE Susceptibility {#s3e}
--------------------------------------------------------------------

Of the 26 studies investigating the association between the *IL10* −592C/A polymorphism and SLE susceptibility, 24 provided enough data to calculate ORs ([Table 5](#pone-0069547-t005){ref-type="table"}). By pooling all studies, the *IL10* −592 C allele was associated with decreased SLE risk under the genetic model of CC+CA vs. AA (OR 0.79, 95% CI 0.64--0.99). A close but not statistically significant association was found under the genetic model of C vs. A (OR 0.87, 95% CI 0.74--1.01). After excluding studies deviating from HWE [@pone.0069547-Zhou1], [@pone.0069547-Chong1], [@pone.0069547-GuarnizoZuccardi1], statistically significant associations were found under the genetic models of C vs. A (OR 0.84, 95% CI 0.70--1.00), CC vs. AA (OR 0.66, 95% CI 0.44--0.99) and CC+CA vs. AA (OR 0.73, 95% CI 0.62--0.88), and a close but not statistically significant association was found under the genetic model of CC vs. AA+CA (OR 0.77, 95% CI 0.59--1.01).

10.1371/journal.pone.0069547.t005

###### Meta-analysis of the *IL10* −592C/A polymorphism and SLE.

![](pone.0069547.t005){#pone-0069547-t005-5}

  Genetic model    Population                  Study                       OR (95% CI)        Statistical model   I^2^    *P* ~Heterogeneity~   *P* ~Egger's\ test~
  --------------- ------------ ------------------------------------- ----------------------- ------------------- ------- --------------------- ---------------------
  C vs. A           Overall                     24                      0.87 (0.74--1.01)          Random         76.0%         \<0.001              **0.021**
                                21[\*](#nt111){ref-type="table-fn"}   **0.84 (0.70--1.00)**        Random         76.4%         \<0.001                0.104
                   Caucasian                     8                      1.02 (0.89--1.16)           Fixed         5.6%           0.387                 0.247
                     Asian                      13                      0.85 (0.67--1.09)          Random         84.5%         \<0.001                0.120
                                11[\*](#nt111){ref-type="table-fn"}     0.80 (0.60--1.07)          Random         84.5%         \<0.001                0.407
  CC vs. AA         Overall                     18                      0.72 (0.48--1.07)          Random         69.1%         \<0.001              **0.008**
                                15[\*](#nt111){ref-type="table-fn"}   **0.66 (0.44--0.99)**        Random         59.6%          0.002                 0.221
                   Caucasian                     7                      1.08 (0.75--1.55)           Fixed         0.0%           0.483                 0.223
                     Asian                       8                      0.71 (0.36--1.39)          Random         81.6%         \<0.001                0.068
                                6[\*](#nt111){ref-type="table-fn"}      0.51 (0.24--1.06)          Random         72.5%          0.003                 0.599
  CC+CA vs. AA      Overall                     18                    **0.79 (0.64--0.99)**        Random         50.4%          0.008                 0.194
                                15[\*](#nt111){ref-type="table-fn"}   **0.73 (0.62--0.88)**         Fixed         32.5%          0.109                 0.425
                   Caucasian                     7                      1.06 (0.74--1.51)           Fixed         0.0%           0.575                 0.330
                     Asian                       8                      0.80 (0.60--1.06)          Random         67.2%          0.003                 0.292
                                6[\*](#nt111){ref-type="table-fn"}    **0.69 (0.51--0.94)**        Random         49.6%          0.078                 0.309
  CC vs. AA+CA      Overall                     18                      0.86 (0.67--1.10)          Random         63.6%         \<0.001              **0.003**
                                15[\*](#nt111){ref-type="table-fn"}     0.77 (0.59--1.01)          Random         59.6%          0.002               **0.004**
                   Caucasian                     7                      1.05 (0.87--1.26)           Fixed         2.1%           0.409                 0.051
                     Asian                       8                      0.79 (0.44--1.43)          Random         78.0%         \<0.001                0.054
                                6[\*](#nt111){ref-type="table-fn"}      0.59 (0.31--1.12)          Random         67.5%          0.009                 0.435

OR: odds ratio; CI: confidence interval; SLE: systemic lupus erythematosus.

exclude the studies deviating from Hardy-Weinberg equilibrium.

In the subgroup analyses by ethnicity, the results showed that only under the genetic model of CC+CA vs. AA the *IL10* −592 C allele was associated with decreased SLE risk among Asians (OR 0.69, 95% CI 0.51--0.94). The associations were not found among Caucasians under any genetic model.

The heterogeneity was significant in the pooling analyses of total available studies and in the subgroup analyses of Asians, and was still significant after excluding studies deviating from HWE [@pone.0069547-Zhou1], [@pone.0069547-Chong1]. Results from funnel plot and Egger's test suggested that publication bias was present in the studies investigating the association between the *IL10* −592C/A polymorphism and SLE susceptibility ([Table 5](#pone-0069547-t005){ref-type="table"}).

Association of the IL10 −1082/−819/−592 Haplotype with SLE Susceptibility {#s3f}
-------------------------------------------------------------------------

There were 16 studies investigating the association between the IL10 −1082/−819/−592 haplotype and SLE susceptibility. GCC, ACC and ATA were the only three haplotypes or account for the vast majority of the IL10 −1082/−819/−592 haplotypes in these studies. Therefore, we just evaluated the three haplotypes ([Table 6](#pone-0069547-t006){ref-type="table"}). The overall meta-analyses showed that the GCC (OR 1.21, 95% CI 1.05--1.40) and the ACC (OR 0.75, 95% CI 0.60--0.95) haplotypes were associated with SLE risk. Further subgroup analyses showed that the GCC haplotype was associated with increased SLE risk among Caucasians (OR 1.25, 95% CI 1.10--1.42) and Asians (OR 1.24, 95% CI 1.00--1.53)and the ACC haplotype was associated with decreased SLE risk among Caucasians (OR 0.77, 95% CI 0.61--0.97) but not among Asians (OR 0.74, 95% CI 0.50--1.12). Excluding the studies deviating from HWE [@pone.0069547-Lazarus1], [@pone.0069547-Zhou1], [@pone.0069547-Lin1], [@pone.0069547-Chong1] yielded similar results except in the subgroup analysis of Asians for the GCC haplotype (OR 1.01, 95% CI 0.75--1.36) and Caucasians for the ACC haplotype (OR 0.79, 95% CI 0.62--1.02).

10.1371/journal.pone.0069547.t006

###### Meta-analysis of the *IL10* −1082/−819/−592 haplotype and SLE.

![](pone.0069547.t006){#pone-0069547-t006-6}

  Genetic model     Population                  Study                       OR (95% CI)        Statistical model   I^2^    *P* ~Heterogeneity~   *P* ~Egger's\ test~
  ---------------- ------------ ------------------------------------- ----------------------- ------------------- ------- --------------------- ---------------------
  GCC vs. others     Overall                     16                    **1.21 (1.05--1.40)**        Random         33.0%          0.098                 0.407
                                 12[\*](#nt113){ref-type="table-fn"}   **1.18 (1.04--1.33)**         Fixed         36.0%          0.103                 0.076
                    Caucasian                     7                    **1.25 (1.10--1.42)**         Fixed         40.5%          0.121                 0.876
                                 6[\*](#nt113){ref-type="table-fn"}    **1.24 (1.01--1.51)**        Random         49.9%          0.076                 0.839
                      Asian                       8                    **1.24(1.00--1.53)**          Fixed         29.3%          0.194                 0.600
                                 5[\*](#nt113){ref-type="table-fn"}      1.01 (0.75--1.36)           Fixed         0.0%           0.450                 0.124
  ACC vs. others     Overall                     16                    **0.75 (0.60--0.95)**        Random         82.7%         \<0.001                0.052
                                 12[\*](#nt113){ref-type="table-fn"}   **0.73 (0.53--0.99)**        Random         84.4%         \<0.001                0.350
                    Caucasian                     7                    **0.77 (0.61--0.97)**        Random         56.2%          0.033                 0.207
                                 6[\*](#nt113){ref-type="table-fn"}      0.79 (0.62--1.02)          Random         59.1%          0.032                 0.333
                                 5[\#](#nt114){ref-type="table-fn"}      0.91 (0.77--1.07)           Fixed         0.0%           0.446                 0.206
                      Asian                       8                      0.74 (0.50--1.12)          Random         90.2%         \<0.001                0.191
                                 5[\*](#nt113){ref-type="table-fn"}      0.66 (0.31--1.40)          Random         93.0%         \<0.001                0.649
  ATA vs. others     Overall                     16                      1.14 (0.94--1.39)          Random         77.7%         \<0.001                0.073
                                 12[\*](#nt113){ref-type="table-fn"}     1.21 (0.91--1.60)          Random         81.1%         \<0.001                0.331
                    Caucasian                     7                      0.96 (0.82--1.11)           Fixed         19.2%          0.284                 0.058
                                 6[\*](#nt113){ref-type="table-fn"}      0.94 (0.80--1.10)           Fixed         28.3%          0.223                 0.108
                      Asian                       8                      1.22 (0.87--1.71)          Random         87.7%         \<0.001                0.195
                                 5[\*](#nt113){ref-type="table-fn"}      1.42 (0.80--2.52)          Random         89.8%         \<0.001                0.874

OR: odds ratio; CI: confidence interval; SLE: systemic lupus erythematosus.

exclude the studies deviating from Hardy-Weinberg equilibrium.

exclude the study by Sobkowiak (2009).

The heterogeneity was significant in the overall analyses. Some of the heterogeneity can be resolved by ethnicity-specific analyses. However, the heterogeneity remained in some ethnicity-specific analyses (ACC among Caucasians and Asians, and ATA among Asians). Excluding the study by Sobkowiak [@pone.0069547-Sobkowiak1] eliminated much of the heterogeneity among Caucasian studies, while for Asians the heterogeneity had no significant change after excluding one study. Funnel plot and Egger's test suggested that publication bias was not apparent ([Table 6](#pone-0069547-t006){ref-type="table"}).

Association of other SNPs in the IL10 Gene with SLE Susceptibility {#s3g}
------------------------------------------------------------------

There were four studies investigating the association between the *IL10* −3575T/A polymorphism and SLE susceptibility. The meta-analyses showed no association under any genetic model. The *I* ^2^ statistic showed that the between-study heterogeneity was not apparent.

There were three studies investigating the association between the *IL10* −2763C/A polymorphism and SLE susceptibility. The meta-analyses showed that the *IL10* −2763 C allele was associated with increased SLE risk (CC+CA vs. AA: OR 2.64, 95% CI 1.01--6.84, fixed model, *I* ^2^ = 57.8%, *P* ~Heterogeneity~ = 0.124). Further analysis showed that the study by Gibson contributed to this association. In this study, the authors studied African Americans.

For other SNPs in the *IL10* gene, only rs3024505 was associated with SLE among Caucasians (1 study, *P* = 3.95×10^−8^).

Discussion {#s4}
==========

IL-10 is a potent stimulator of B cells in one way and a strong inhibitor of antigen-presenting cells and T cells in another way. Therefore, it plays an important role in immune and inflammatory process and aberrant expression of IL-10 contributes to the development of autoimmune diseases [@pone.0069547-Groux1]. Polymorphisms in the IL-10 gene may alter IL-10 production, and thus influencing susceptibility to autoimmune diseases. For asthma, rheumatoid arthritis, type 1 diabetes, and graft-versus-host disease, observational studies have demonstrated the gene-disease association [@pone.0069547-Iyer1]. In the past 15 years, a number of case-control studies have also been conducted to investigate the association in SLE. In this meta-analysis, we collected all available published case-control studies on the association between the IL-10 gene polymorphisms and SLE susceptibility and combined them when combinable, hoping to give a whole picture of this topic.

Previous meta-analysis has found that the CA23 allele of the *IL-10.G* microsatellites is associated with SLE [@pone.0069547-Nath1]. Our meta-analysis, which included more studies, failed to replicate this finding. But our meta-analysis showed an association between the CA27 allele and SLE in Caucasian patients without between-study heterogeneity. This association has never been reported in each individual study. Thus, our meta-analysis produced a new finding about the association between the *IL-10.G* microsatellites and SLE. In addition, we found an association between the CA21 allele and SLE in Asian patients with between-study heterogeneity. However, it should be noticed that different alleles in the *IL-10.G* microsatellites have been linked with SLE risk in different studies. Ethnicity and patient heterogeneity may explain it. The allele distributions of the *IL-10.G* microsatellites are often different among different populations; some subgroup patients such as patients with anti-Sm antibodies or with nephritis tend to correlate with certain *IL-10.G* alleles, while their distributions are different among different studies [@pone.0069547-Ou1], [@pone.0069547-Schotte1]. It is also likely that the *IL-10.G* microsatellites are markers of disease susceptibility due to linkage disequilibrium with some causal variation.

This meta-analysis showed a relative solid association between the *IL-10* −1082 G/A polymorphisms and SLE among Caucasians, because the results were consistent under three genetic models (G vs. A, GG vs. AA, and GG+GA vs. AA) without between-study heterogeneity and insensitive to HWE status in control groups. An earlier meta-analysis, because of very limited studies included, failed to result in a positive finding [@pone.0069547-Nath1]. Two later meta-analyses, which included more studies but still fewer than ours, yielded similar findings with ours [@pone.0069547-Song1], [@pone.0069547-Zhou2]. For Asians, studies deviating from HWE and the study by Shen [@pone.0069547-Shen1]were the main source of heterogeneity in this meta-analysis. Excluding these studies resulted in a significant association under two genetic models and a close but not significant association under the other models. Previous meta-analyses also supported an association of the *IL-10* −1082 G/A polymorphisms among Asians, but the numbers of included Asian studies were smaller than ours [@pone.0069547-Nath1], [@pone.0069547-Zhou2]. Turner et al. reported that the *IL-10* −1082G allele was associated with higher IL-10 production following ConA stimulation of human peripheral blood lymphocytes *in vitro* [@pone.0069547-Turner1]. Other researchers performed similar assays and reported contradictory associations between IL-10 production and genotype [@pone.0069547-Rees1]. Therefore, functional studies do not fully support the hypothesis that the *IL-10* −1082 G/A polymorphisms have an effect on IL-10 production and thus influencing disease susceptibility. The IL-10 −1082 G/A polymorphisms may also be a marker of disease susceptibility due to linkage disequilibrium.

All studies from Europe showed a complete linkage disequilibrium at positions −819 and −592 in the *IL-10* gene. Thus, among Caucasians our meta-analysis produced consistent findings for the *IL-10* −819 C/T and −592 C/A. But for studies from Asia, 4 of them did not show a complete linkage disequilibrium at the two positions [@pone.0069547-Shen1], [@pone.0069547-Lin1], [@pone.0069547-Hirankarn1], [@pone.0069547-Yu2]. Therefore, among Asians our meta-analysis produced inconsistent findings. After excluding studies deviating from HWE, we found that among Asians the *IL-10* −592 C/A polymorphisms were significantly associated with SLE under the genetic model of CC+CA vs. AA and showed a trend of association but not statistically significant under other models. This may contribute to positive findings from overall analyses of the IL-10 −592 C/A polymorphisms when excluding studies deviating from HWE. Eskdale et al. reported that the C allele at −592 of the *IL-10* gene or its associated haplotype was related to increased production of IL-10 by whole blood or PBMCs [@pone.0069547-Eskdale1], while other researchers reported conflicting associations [@pone.0069547-Temple1]. For patients with different diseases, the direction of association was also different between IL-10 production and the *IL-10* −592 C/A polymorphisms [@pone.0069547-Claudino1], [@pone.0069547-Kurreeman1], [@pone.0069547-TorresPoveda1]. Therefore, the evidence from functional studies is not strong enough to support a causal association between them.

Because of linkage disequilibrium, GCC, ACC and ATA were the only three haplotypes or account for the vast majority of the *IL10* −1082/−819/−592 haplotypes in included studies. Overall meta-analysis showed that the GCC haplotype was associated with increased and the ACC haplotype with decreased SLE susceptibility and the results were sensitive to ethnicity and HWE status in control groups. These findings were similar with a recent meta-analysis [@pone.0069547-Song1]. For the ATA haplotype, our meta-analysis did not produce any association with SLE, which is conflicting with the recent meta-analysis [@pone.0069547-Song1]. Considering the absolutely more studies included in our meta-analysis, we are more confident with our findings. As the GCC haplotype was almost the only source of G allele at −1082 of the *IL-10* gene, similar findings should be yielded from the analysis of the GCC haplotype and the *IL-10* −1082 G/A polymorphisms. This can be seen in our present meta-analysis. Because of the almost complete linkage disequilibrium, functional findings about the *IL-10* −1082 G/A polymorphisms are suitable for the GCC haplotype.

This meta-analysis involving 7948 cases and 11866 controls used an exhaustive search strategy in recommended databases without language restrictions [@pone.0069547-Little1]. The number of included studies was at least twice as many as those in previous meta-analysis. Thus, our meta-analysis has more statistical power to detect positive findings and allow ethnicity-specific analysis. Our meta-analysis also identified and excluded studies that used overlapping data [@pone.0069547-Rood1], [@pone.0069547-vanderLinden1], while previous meta-analyses treated them as separate study [@pone.0069547-Nath1], [@pone.0069547-Song1], [@pone.0069547-Zhou2]. In addition, we performed sensitive analysis by excluding studies deviating from HWE. Some studies suggested that deviations from HWE in healthy populations may be a sign of selection bias or population stratification [@pone.0069547-Attia1]. Consistent findings are solider from sensitive analysis by HWE.

Some caveats need to be noted regarding the present study. First, there was significant heterogeneity among included studies, especially among studies from Asia. Pan et al. reported that Chinese gene-disease association studies often have more heterogeneity than others [@pone.0069547-Pan1]. In our systematic review and meta-analysis, most Asian studies were from China and some of them were the main source of heterogeneity. However, much of the heterogeneity can be eliminated through sensitive analysis. Second, publication bias from Egger's test was apparent in some analyses of the *IL-10* −819 C/T and −592 C/A polymorphisms. This may be due to reporting bias, other biases or genuine heterogeneity, and it may be difficult to determine which is the case [@pone.0069547-Little1]. As we included more studies than previous meta-analyses and these meta-analyses did not show significant publication bias from Egger's test, this is more likely to be due to other biases or genuine heterogeneity. Third, for the *IL10* −3575T/A and −2763C/A, relevant studies are quite few; there were also very limited studies conducted among black people; more studies needed to duplicate the association of rs3024505 with SLE. Fourth, to our knowledge, the SNPs that are related with SLE in this study have not been highlighted in recent GWAS focused on SLE except the SNP rs3024505. It is common that findings are different from candidate gene studies and GWAS studies. The reasons are currently hard to explain. Some possible reasons include: variation in demographic profile of controls, linkage disequilibrium in different populations, variation in accuracy of genotyping methods, false discovery, and confounding factors.

In summary, this meta-analysis showed that the CA27 allele of the *IL-10.G* microsatellites, the *IL-10* −1082G/A polymorphism and its associated haplotype of GCC are associated with SLE susceptibility among Caucasians and the CA21 allele of the *IL-10.G* microsatellites, the *IL-10* −1082G/A and −592 C/A polymorphisms and their associated haplotype of GCC may be associated with SLE susceptibility among Asians. It is worthwhile to note that this is the first time to report an association between the CA27 allele of the *IL-10.G* microsatellites and SLE among Caucasians. Further studies are needed to confirm these findings. More studies are also needed to duplicate the associations between SLE and some rarely studied SNPs such as rs3024505.
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